Trastuzumab-Pertuzumab Plus Eribulin or Taxane as First-Line Chemotherapy for Human Epidermal Growth Factor 2–Positive Locally Advanced/Metastatic Breast Cancer: The Randomized Noninferiority Phase III EMERALD Trial

The results suggested that eribulin + HP is an option for first-line treatment of locally advanced/metastatic HER2+ BC.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-01-09
DOI
https://doi.org/10.1200/jco-24-01888
Citations
8
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
8.36
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trastuzumab-Pertuzumab Plus Eribulin or Taxane as First-Line Chemotherapy for Human Epidermal Growth Factor 2–Positive Locally Advanced/Metastatic Breast Cancer: The Randomized Noninferiority Phase III EMERALD Trial

Natsuko Mori, Masato Takahashi, Junji Tsurutani, Hiroki Hasegawa et al.
8 citations
Journal of Clinical Oncology
HER2/EGFR in Cancer Research
8.36
article

Trastuzumab-Pertuzumab Plus Eribulin or Taxane as First-Line Chemotherapy for Human Epidermal Growth Factor 2–Positive Locally Advanced/Metastatic Breast Cancer: The Randomized Noninferiority Phase III EMERALD Trial

Natsuko Mori, Masato Takahashi, Junji Tsurutani, Hiroki Hasegawa, Akiyo Yoshimura, Shigehira Saji, Toshinari Yamashita, Toshimi Takano, Yohei Uchida, Michiko Tsuneizumi, Tsutomu Iwasa, Yoichi Naito, Norikazu Masuda, Tsuguo Iwatani, Masahiro Kitada, Toru Higuchi, Hiroshi Tada, Satoshi Morita, Kazuhiro Araki, Kei Koizumi
article en
8 citations

Abstract

The results suggested that eribulin + HP is an option for first-line treatment of locally advanced/metastatic HER2+ BC.

Journal of Clinical OncologyVol. 43(11)
SHOWA Medical University (JP), Fukushima Medical University (JP), Asahikawa Medical University (JP), Kyoto University (JP), Kanagawa Prefectural Hospital Organization (JP), Hamamatsu University School of Medicine (JP), Tohoku University Hospital (JP), Kindai University Hospital (JP), Okayama University Hospital (JP), Seirei Hamamatsu General Hospital (JP), Aichi Cancer Center (JP), Shizuoka General Hospital (JP), The Cancer Institute Hospital (JP), Hokkaido University Hospital (JP), National Cancer Center Hospital East (JP), Saitama Red Cross Hospital (JP), Kanagawa Cancer Center, National Hospital Organization Saitama Hospital, Eisai (Japan) (JP)
Good health and well-being
Openalex Percentile: Top 2%
HER2/EGFR in Cancer Research
8.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.